Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6190)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11087)
  2. Hematologic Malignancies, Division of (10638)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3721)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (308)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13544)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Unmasking hidden mutational footprints of therapy in pediatric tumors
    Meeting Abstract

    Layeghifard, M.; Díaz-Gay, M.; Ballester, P. L.; Papaemmanuil, E.; Cowley, M.; Villani, A.; Alexandrov, L. B.; Shlien, A.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • An active learning platform for predictive oncology in rare cancers
    Meeting Abstract

    Tosh, C.; Sanchez, G. I.; Stockfisch, E.; Kung, A.; Dela Cruz, F.; Slotkin, E.; Tansey, W.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Haematotoxicity risk factors for sub-optimal outcomes following obecabtagene autoleucel for relapsed/refractory B-cell acute lymphoblastic leukaemia
    Meeting Abstract

    Roddie, C.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Sandhu, K. S.; Abedi, M.; Shah, B. D.; Bishop, M. R.; DeAngelo, D. J.; Tholouli, E.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Tumour burden-guided dosing in the FELIX study of obecabtagene autoleucel in adult R/R B-ALL
    Meeting Abstract

    Yallop, D.; Jabbour, E.; Sandhu, K. S.; Shaughnessy, P.; Logan, A. C.; Abedi, M.; Shah, B. D.; Bishop, M. R.; Park, J. H.; DeAngelo, D. J.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Obecabtagene autoleucel with/without consolidative stem cell transplantation in relapsed/refractory B-cell acute lymphoblastic leukaemia: Patient outcomes
    Meeting Abstract

    Tholouli, E.; Park, J. H.; Jabbour, E.; Shah, B. D.; Shaughnessy, P.; Logan, A. C.; Sandhu, K. S.; Abedi, M.; Bishop, M. R.; DeAngelo, D. J.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Safety of tyrosine kinase inhibitor discontinuation for pregnancy in patients with established chronic myeloid leukaemia
    Meeting Abstract

    Chan, C. N. J.; Robertson, H. F.; Apperley, J. F.; Milojkovic, D.; Innes, A.; Claudiani, S.; Khan, A.; Abruzzese, E.; Mauro, M.; Mahdi, A.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • MagnetisMM-3: Long-term update and outcomes of less frequent dosing of elranatamab in relapsed/refractory multiple myeloma
    Meeting Abstract

    Searle, E.; Prince, H. M.; Bahlis, N.; Rodriguez-Otero, P.; Karlin, L.; Akard, L.; Varshavsky-Yanovsky, A.; Nagai, Y.; Vesole, D.; Chu, M.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Depth of MRD-negative remission and outcomes in adults with R/R B-ALL treated with obecabtagene autoleucel
    Meeting Abstract

    Roddie, C.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Sandhu, K. S.; Abedi, M.; Shah, B. D.; Bishop, M. R.; DeAngelo, D. J.; Tholouli, E.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Real-world treatment outcomes of venetoclax in acute myeloid leukemia in Great Britain (ARC)
    Meeting Abstract

    Kew, H.; O'nions, J.; Errico, G.; Murthy, V.; Sweeney, C.; Kaur, H.; Mohite, U.; Floro, L.; Ayto, R.; Alvares, C.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Real-world treatment patterns and outcomes in AML patients treated with venetoclax in Great Britain (ARC)
    Meeting Abstract

    Kew, H.; O'nions, J.; Errico, G.; Murthy, V.; Sweeney, C.; Alvares, C.; Goldberg, A.; Xu, Y.; Thomas, F.; Vyas, P.
    British Journal of Haematology (2025)

    Fulltext@MSK | Save